Phase 2a trial of RAP-219 in refractory focal epilepsy fully enrolled and on track for topline results in September 2025 Phase 2a trial of RAP-219 in refractory focal epilepsy fully enrolled and on track for topline results in September ...

CHICAGO, June 2, 2025 /PRNewswire/ -- Edward and Ludmila Smolyansky, beneficial owners of approximately 27% of Lifeway Foods LWAY, today issued a statement expressing serious concerns about the company's Q1 2025 performance and what they describe as the Board's ongoing pattern of poor governance ...

A Republican-led tax proposal and recent comments from President Donald Trump appear to be weighing on shares. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right here. Ford Motor Company F shares are trading lower Monday.

Moderna announces its new COVID-19 vaccine secured FDA clearance for seniors and at-risk individuals. Moderna's mNEXSPIKE shows a higher vaccine efficacy as well as a similar safety profile compared to the company's original COVID-19 vaccine. Rebound or breakdown?

NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Tempus AI, Inc. ( "Tempus" or the "Company" ) TEM. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Hallador Energy Company ( "Hallador" or the "Company" ) HNRG. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

SCOTTSDALE, Ariz., June 02, 2025 ( GLOBE NEWSWIRE ) -- Elite Clinical Network ( ECN ) , a fully-integrated clinical research site network, has appointed Christopher ( "Chris" ) Brennan as its Chief Executive Officer.

NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Apple Inc. ( "Apple" or the "Company" ) AAPL. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Photronics, Inc. ( "Photronics" or the "Company" ) PLAB. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Zenas To Contact Him Directly To Discuss Their Options